- Home
- BDSX vs XBIT Comparison
BDSX vs XBIT Comparison
Compare BDSX & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDSX
- XBIT
- Stock Information
- Founded
- BDSX 2005
- XBIT 2005
- Country
- BDSX United States
- XBIT United States
- Employees
- BDSX N/A
- XBIT N/A
- Industry
- BDSX Precision Instruments
- XBIT Pharmaceuticals and Biotechnology
- Sector
- BDSX Health Care
- XBIT Health Care
- Exchange
- BDSX Nasdaq
- XBIT Nasdaq
- Market Cap
- BDSX 200.0M
- XBIT 203.2M
- IPO Year
- BDSX 2020
- XBIT 2015
- Fundamental
- Price
- BDSX $1.20
- XBIT $6.62
- Analyst Decision
- BDSX Strong Buy
- XBIT
- Analyst Count
- BDSX 4
- XBIT 0
- Target Price
- BDSX $3.08
- XBIT N/A
- AVG Volume (30 Days)
- BDSX 732.5K
- XBIT 57.1K
- Earning Date
- BDSX 11-01-2024
- XBIT 11-13-2024
- Dividend Yield
- BDSX N/A
- XBIT N/A
- EPS Growth
- BDSX N/A
- XBIT N/A
- EPS
- BDSX N/A
- XBIT N/A
- Revenue
- BDSX $65,562,000.00
- XBIT N/A
- Revenue This Year
- BDSX $46.97
- XBIT N/A
- Revenue Next Year
- BDSX $30.43
- XBIT N/A
- P/E Ratio
- BDSX N/A
- XBIT N/A
- Revenue Growth
- BDSX 48.92
- XBIT N/A
- 52 Week Low
- BDSX $1.11
- XBIT $3.54
- 52 Week High
- BDSX $2.21
- XBIT $9.96
- Technical
- Relative Strength Index (RSI)
- BDSX 28.77
- XBIT 41.68
- Support Level
- BDSX $1.11
- XBIT $6.36
- Resistance Level
- BDSX $1.45
- XBIT $7.43
- Average True Range (ATR)
- BDSX 0.09
- XBIT 0.50
- MACD
- BDSX -0.02
- XBIT -0.10
- Stochastic Oscillator
- BDSX 24.32
- XBIT 13.27
About BDSX Biodesix Inc.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.